Table 2.
Group 1 ≤20 ng/mL n = 145 |
Group 2 21–30 ng/mL n = 254 |
Group 3 ≥30 ng/mL n = 201 |
P | |
---|---|---|---|---|
GDM | 8 (5.5%) | 24 (9.5%) | 22 (11%) | 0.185 |
PIH | 3 (2.1%) | 12 (4.7%) | 4 (1.9%) | 0.128 |
PPH | 10 (6.9%) | 17 (6.7%) | 3 (1.5%) | 0.009 |
FBW | ||||
≥2500 g | 139 (95.9%) | 234 (92.1%) | 190 (94.5%) | 0.338 |
<2500 | 6 (4.1%) | 20 (7.9%) | 11 (5.5%) | 0.345 |
GA | ||||
≥ 37 wks | 141 (97.2%) | 239 (94.1%) | 194 (96.5%) | 0.312 |
<37 wks | 4 (2.8%) | 15 (5.9%) | 7 (3.5%) | 0.432 |
FBW, fetal body weight; GA, gestational age; GDM, gestational diabetes; PIH, pregnancy-induced hypertension; PPH, postpartum hemorrhage.
P < 0.05 is significant.
Bold values mean that: P< 0.05.